# Intensity Therapeutics Recognized with GHP Magazine's 2026 Healthcare & Pharmaceutical Award
Canonical URL: https://biopharmsignal.com/news/INTS/intensity-therapeutics-recognized-with-ghp-magazine-s-2026-healthcare-and-pharmaceutical-award
Ticker: INTS
Company: Intensity Therapeutics
Source: Intensity Therapeutics
Published: 2026-05-14 12:00 EST
Original Source URL: https://ir.intensitytherapeutics.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-05-14 12:00 EST — [Intensity Therapeutics Recognized with GHP Magazine's 2026 Healthcare & Pharmaceutical Award](https://biopharmsignal.com/news/INTS/intensity-therapeutics-recognized-with-ghp-magazine-s-2026-healthcare-and-pharmaceutical-award) — Source: Intensity Therapeutics
- 2026-05-07 20:06 EST — [Intensity Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update](https://biopharmsignal.com/news/INTS/intensity-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update) — Source: Intensity Therapeutics
- 2026-04-15 13:15 EST — [Intensity Therapeutics Recognized with Pinnacle Award for Excellence in Healthcare Innovation](https://biopharmsignal.com/news/INTS/intensity-therapeutics-recognized-with-pinnacle-award-for-excellence-in-healthcare-innovation) — Source: Intensity Therapeutics
- 2026-03-27 20:12 EST — [Intensity Therapeutics Reports 2025 Year End Financial Results and Highlights, and Provides Corporate Update](https://biopharmsignal.com/news/INTS/intensity-therapeutics-reports-2025-year-end-financial-results-and-highlights-and-provides-corporate-update) — Source: Intensity Therapeutics
- 2026-03-24 12:00 EST — [Intensity Therapeutics Strengthens IP Portfolio with Issuance of New Patent in the US](https://biopharmsignal.com/news/INTS/intensity-therapeutics-strengthens-ip-portfolio-with-issuance-of-new-patent-in-the-us) — Source: Intensity Therapeutics
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)